Gastrointestinal (GI) malignancies refer to cancers that develop in the digestive system, including the oesophagus, stomach, intestines, colon, rectum, liver, pancreas and biliary tract. These cancers can affect digestion, nutrient absorption and overall health. Early diagnosis and appropriate treatment are important for managing the disease and improving the patient's quality of life.
If you are searching for GI Malignancy Treatment in Faridabad, consulting an experienced medical oncologist can help you understand your diagnosis and explore appropriate treatment options.
Dr. Ashish B. Agrawal is a Medical Oncologist, Haematologist and BMT specialist with experience in managing various types of cancer. His approach focuses on evidence-based oncology, personalised treatment planning and coordination with other specialists when required.
Depending on the cancer type and stage, treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy or a combination of these approaches.
Gastrointestinal cancer develops when abnormal cells grow uncontrollably in any part of the digestive system. The disease may remain localised or spread to nearby tissues, lymph nodes or distant organs.
The treatment approach depends on the cancer's location, stage, pathology, molecular characteristics and the patient's general health.
Patients seeking GI Malignancy Treatment in Faridabad should undergo appropriate diagnostic evaluation to identify the exact cancer type and determine the most suitable treatment strategy.
Oesophageal cancer develops in the food pipe that connects the mouth to the stomach. Common symptoms may include difficulty swallowing, unexplained weight loss and persistent discomfort while eating.
Treatment depends on the tumour's location, stage and histological type and may involve surgery, chemotherapy, radiation therapy or a combination of treatments.
Stomach cancer, also called gastric cancer, develops in the lining of the stomach. Symptoms may include persistent indigestion, abdominal discomfort, loss of appetite, nausea and unexplained weight loss.
Treatment may involve surgery, chemotherapy, targeted therapy or immunotherapy in selected cases, depending on the stage and tumour characteristics.
Colorectal cancer affects the colon or rectum. Warning signs may include changes in bowel habits, blood in the stool, persistent abdominal discomfort, anaemia or unexplained weight loss.
Treatment depends on the stage and may include surgery, chemotherapy, radiation therapy for selected rectal cancers, targeted therapy or immunotherapy for eligible patients.
Liver cancer includes primary cancers such as hepatocellular carcinoma, which develops in liver cells. Risk factors may include chronic hepatitis infection, cirrhosis and certain other liver conditions.
Treatment options depend on liver function, tumour size and location, disease stage and overall health. Management may involve local procedures, surgery, systemic therapy or other specialist-led approaches.
Pancreatic cancer develops in the pancreas, an organ involved in digestion and blood sugar regulation. Symptoms may include abdominal or back pain, jaundice, appetite changes and unexplained weight loss.
Treatment may involve surgery, chemotherapy, targeted therapy or other approaches, depending on the type and extent of the cancer.
Biliary tract cancers develop in the bile ducts or gallbladder. Symptoms may include jaundice, itching, abdominal discomfort and changes in urine or stool colour.
Treatment is determined by the tumour's location, stage and whether surgical removal is possible.
Symptoms of gastrointestinal cancers vary according to the affected organ. Some symptoms may also occur in non-cancerous digestive conditions, but persistent or unexplained changes require medical assessment.
Common symptoms include:
These symptoms do not automatically indicate cancer. However, early evaluation can help identify the underlying cause and determine whether further investigations are required.
Accurate diagnosis is essential for planning effective GI malignancy treatment. The investigations recommended depend on the patient's symptoms, suspected cancer type and initial clinical findings.
The doctor reviews the patient's symptoms, medical history, family history, risk factors and previous test results.
Endoscopy may be used to examine the oesophagus, stomach and upper digestive tract. Colonoscopy helps examine the colon and rectum for abnormal growths or suspicious lesions.
A biopsy involves collecting a tissue sample for laboratory examination. It is generally required to confirm the diagnosis and identify the cancer type.
CT scans, MRI, ultrasound or PET-CT may be recommended in selected cases to assess the tumour's size, location and possible spread.
Blood tests may help assess general health and organ function. Certain tumour markers may be useful in specific cancers, but they cannot independently confirm or exclude most gastrointestinal malignancies.
In selected cancers, molecular tests and biomarker analysis can help identify patients who may benefit from targeted therapy or immunotherapy.
Not every patient requires every investigation. Testing is tailored to the suspected diagnosis and clinical situation.
The best treatment depends on the affected organ, cancer stage, pathology, molecular characteristics and the patient's overall health. Patients seeking GI Malignancy Treatment in Faridabad may require one or several treatment approaches.
Chemotherapy uses medicines to destroy cancer cells or control their growth. It may be recommended before surgery, after surgery or for advanced cancers where systemic treatment is appropriate.
The medicines and schedule depend on the cancer type, stage, previous treatments and the patient's ability to tolerate therapy.
Targeted therapy focuses on specific proteins, genes or pathways involved in cancer growth. It may be suitable for selected patients whose tumour testing identifies relevant molecular targets.
The decision to use targeted therapy depends on the cancer type, test results, disease stage and current clinical recommendations.
Immunotherapy helps the immune system recognise and attack cancer cells. It may be appropriate for selected gastrointestinal cancers, depending on factors such as tumour biomarkers, cancer type and disease stage.
For example, certain patients with colorectal, gastric or other gastrointestinal cancers may be considered for immunotherapy when their clinical and molecular findings support its use.
Immunotherapy is not suitable for every patient, and its potential benefits and risks should be discussed with the treating oncologist.
Surgery may be recommended when the tumour can be removed safely and the patient's condition allows it. The procedure depends on the affected organ, tumour location and stage.
Surgery may be combined with chemotherapy or radiation therapy to improve disease control when appropriate.
Radiation therapy uses high-energy radiation to destroy cancer cells. It may be used in selected gastrointestinal cancers, particularly certain rectal and oesophageal cancers, depending on the treatment plan.
The radiation oncology team determines whether radiation is appropriate and how it should be coordinated with other therapies.
Personalised cancer treatment considers the tumour's biological characteristics, stage, the patient's health and individual treatment goals. A multidisciplinary team may include medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists and other specialists.
This coordinated approach helps determine the appropriate sequence of treatments and supports ongoing monitoring.
Choosing a medical oncologist is an important step in managing gastrointestinal cancer. Dr. Ashish B. Agrawal has specialised training in Medical Oncology and General Medicine and experience in managing complex malignancies.
Patients may benefit from:
Treatment decisions and expected outcomes vary according to the individual diagnosis and response to therapy.
Early evaluation of persistent digestive symptoms can help identify their cause and determine whether further investigations are needed. Certain gastrointestinal cancers may not cause noticeable symptoms during their early stages, making recommended screening particularly important for eligible individuals.
Screening recommendations depend on age, family history, inherited risk and other medical factors. Individuals with a strong family history or known hereditary cancer syndrome may need earlier or more frequent assessment.
If you are looking for GI Malignancy Treatment in Faridabad, timely consultation can help you understand the diagnostic process and discuss appropriate management options.
Consider consulting a medical oncologist if:
Bring previous biopsy reports, imaging scans, laboratory results and treatment records to your consultation.
Gastrointestinal malignancies require an individualised approach based on the affected organ, cancer stage, pathology and overall health. Appropriate treatment may involve surgery, chemotherapy, radiation therapy, targeted therapy or immunotherapy.
Dr. Ashish B. Agrawal provides specialised medical oncology care for patients with different types of cancer. If you are considering GI Malignancy Treatment in Faridabad, a consultation can help you understand your diagnosis, discuss suitable treatment approaches and plan the next steps in your care.
Dr. Ashish B. Agrawal is a Medical Oncologist with experience in managing different cancers. Contact his current hospital or clinic to confirm consultation availability and the services offered.
Gastrointestinal cancers include cancers of the oesophagus, stomach, colon, rectum, liver, pancreas and biliary tract. Treatment depends on the affected organ, cancer type and disease stage.
Treatment may include surgery, chemotherapy, radiation therapy, targeted therapy or immunotherapy. The appropriate approach depends on the cancer's location, stage, pathology and molecular characteristics.
No. Chemotherapy is not required in every case. Some patients may need surgery or other treatments, while others benefit from a combination of therapies. Recommendations depend on the specific diagnosis and stage.
Immunotherapy can benefit selected patients with certain gastrointestinal cancers. Its suitability depends on the cancer type, stage, biomarker results, previous treatments and overall health.
Warning signs may include unexplained weight loss, persistent abdominal pain, blood in the stool, changes in bowel habits, difficulty swallowing or jaundice. These symptoms can have other causes and should be evaluated if persistent or unexplained.
Contact Dr. Ashish B. Agrawal's current hospital or clinic to confirm appointment availability. Bring your biopsy reports, imaging results, laboratory investigations and previous treatment records for review.
Dr. Ashish B. Agrawal is a Medical Oncologist, Haematologist and BMT specialist with expertise in managing various cancers and blood disorders, including breast cancer, lung cancer, lymphoma, gastrointestinal cancers, and head and neck cancers.
He provides medical oncology care for several cancers, including breast cancer, lung cancer, gastrointestinal malignancies, head and neck cancers, lymphoma, and other complex malignancies, depending on the patient's condition.
Yes, immunotherapy is one of Dr. Ashish's areas of expertise. It may be recommended for suitable patients based on their cancer type, stage, biomarkers, overall health, and treatment requirements.
Precision medicine involves using relevant tumour and patient-specific information to help select the most appropriate treatment. It can help doctors develop a more personalised approach to cancer management.
Yes. Dr. Ashish has expertise in Haematology and blood cancer management, including conditions such as lymphoma and other haematological malignancies. Treatment is planned according to the specific diagnosis and individual patient requirements.
With 18+ years of clinical experience in Medical Oncology and Haematology, Dr. Ashish offers comprehensive and personalised cancer care. His approach combines specialised expertise, evidence-based treatment, advanced oncology therapies, and compassionate patient care.